Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 2Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Multiple Myeloma 21Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Burkitt Lymphoma 6Leukemia, Biphenotypic, Acute 5Recurrence 3Smoldering Multiple Myeloma 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 2Lymphoma, T-Cell 2Lymphoma, Large B-Cell, Diffuse 2Leukemia 2Immunoglobulin Light-chain Amyloidosis 2Hodgkin Disease 2Blastic Plasmacytoid Dendritic Cell Neoplasm 2Renal Insufficiency 1Proteostasis Deficiencies 1Neoplasms, Plasma Cell 1Neoplasms 1Meningioma 1Lymphoma, B-Cell, Marginal Zone 1Lymphoma, B-Cell 1Lymphoma 1Lymphodepleting Chemotherapy 1Lung Neoplasms 1Leukemia, Myelomonocytic, Chronic 1Hematologic Neoplasms 1Down Syndrome 1Cytokine Release Syndrome 1Carcinoma, Non-Small-Cell Lung 1Carcinoma 1

Interventions

Magnetic Resonance Spectroscopy 23Radiosurgery 21Temozolomide 14Bevacizumab 12pembrolizumab 10Specimen Handling 9Nivolumab 8Radiotherapy 7Ipilimumab 7Magnetic Resonance Imaging 6Cyclophosphamide 5Capecitabine 5Blood Specimen Collection 5encorafenib 4Radiation 4Neuropsychological Tests 4Mental Status and Dementia Tests 4Memantine 4Carboplatin 4fludarabine 3fluciclovine F-18 3binimetinib 3abemaciclib 3Watchful Waiting 3Proton Therapy 3Etoposide 3Dexamethasone 3Adrenal Cortex Hormones 3trastuzumab deruxtecan 2sacituzumab govitecan 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Brain Neoplasms × Calcium Dobesilate × Clear all
NCT06132685 2026-02-10

Post-Operative Dosing of Dexamethasone in Patients With Brain Tumors After a Craniotomy, PODS Trial

Emory University

Phase 2 Recruiting
200 enrolled
CNS

Brain Neoplasms, Meningioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡